Posted by Michael Wonder on 09 Dec 2020
Even before year end, 2020's new drug approvals match FDA's 2019 stats
7 December 2020 - The US FDA has kept its new drug approvals for 2020 on track to match or best approvals in 2019, despite the COVID-19 pandemic.
By 4 December 2020, FDA had amassed a list of 48 new molecular entities and new therapeutic biological products approved by the agency’s Center for Drug Evaluation and Research, equaling the total for 2019.
